Valion Bio, Inc. - 8-K Filing

Valion Bio advances Entolimod platform with government engagement, domestic manufacturing scale-up, and oncology expansion plans (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $TIVC

Read the full article at SEC EDGAR

More Regulatory news